Erratum: An allosteric role for receptor activity-modifying proteins in defining GPCR pharmacology

Joseph J Gingell, John Simms, James Barwell, David R Poyner, Harriet A Watkins, Augen A Pioszak, Patrick M Sexton, Debbie L Hay

Research output: Contribution to journalArticle

2 Downloads (Pure)

Abstract


Original languageEnglish
Article number16020
JournalCell Discovery
Volume2
Publication statusPublished - 21 Jun 2016
Externally publishedYes

Bibliographical note

This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material.

Keywords

  • Published Erratum

Fingerprint Dive into the research topics of 'Erratum: An allosteric role for receptor activity-modifying proteins in defining GPCR pharmacology'. Together they form a unique fingerprint.

  • Cite this

    Gingell, J. J., Simms, J., Barwell, J., Poyner, D. R., Watkins, H. A., Pioszak, A. A., ... Hay, D. L. (2016). Erratum: An allosteric role for receptor activity-modifying proteins in defining GPCR pharmacology. Cell Discovery, 2, [16020].